3261 - 3270 of 8808 Results
Title
Year
-
OPENTitle: IntranasalNAP(davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synucleinJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 2Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.65Best OA location URL: https://doi.org/10.1002/prp2.65Citation Count: 43
-
OPENTitle: Bridging a mechanistic gap from diet to synapsesJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 120Issue #: 33Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2309992120Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10433296/pdf/pnas.202309992.pdfCitation Count: 1
-
OPENTitle: Environmental Risk Factors for Progressive Supranuclear PalsyJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 14Issue #: 2Start Page: 103End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20173Best OA location URL: https://doi.org/10.14802/jmd.20173Citation Count: 23
-
OPENTitle: Paper Spray Ionization Ion Mobility Mass Spectrometry of Sebum Classifies Biomarker Classes for the Diagnosis of Parkinson’s DiseaseJournal Name: JACS AuPublisher: American Chemical Society (ACS)Vol: 2Issue #: 9Start Page: 2013End Page: 2022Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/jacsau.2c00300Best OA location URL: https://doi.org/10.1021/jacsau.2c00300Citation Count: 35
-
RESTRICTEDTitle: Regional cerebral cholinergic vesicular transporter correlates of visual contrast sensitivity in Parkinson's disease: Implications for visual and cognitive functionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 131Issue #:Start Page: 107229End Page: 107229Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107229Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107229Citation Count: 2
-
OPENTitle: Reply to: Hypoxia treatment of Parkinson’s disease may disrupt the circadian systemJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-023-03281-9Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-023-03281-9Citation Count: 0
-
RESTRICTEDTitle: Structure-based optimization and binding assays for discovery of tau PET radiotracers: synthesis and in vivo evaluation of [11C]Z-3272Journal Name: Canadian Journal of ChemistryPublisher: Canadian Science PublishingVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1139/cjc-2025-0058Best OA location URL: https://doi.org/10.1139/cjc-2025-0058Citation Count: 0
-
OPENTitle: Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson′s diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1531Issue #:Start Page: 37End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2013.07.025Best OA location URL: http://doi.org/10.1016/j.brainres.2013.07.025Citation Count: 28
-
OPENTitle: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2016.00174Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2016.00174/pdfCitation Count: 10
-
OPENTitle: The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein PathologyJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page: 311End Page: 311Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2017.00311Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2017.00311/pdfCitation Count: 22